Group 2 Innate Lymphoid Cells: Team Players in Regulating Asthma
Citation
- Verified title: Group 2 Innate Lymphoid Cells: Team Players in Regulating Asthma
- Publication year: 2021
- DOI: 10.1146/annurev-immunol-110119-091711
- Metadata source: crossref-title (confidence: high)
- Original local title: Group 2 Innate Lymphoid Cells Team Players in Regulating Asthma
Ingest Mode
- Mode:
focused manual crystallization mode - Meaning: this source page was manually reviewed for source text, model context, assay directness, and claim boundaries.
- Durable synthesis status: selected source-specific claims were propagated into entity/topic/digest pages only where evidence strength and context labels are preserved.
Source Type
- review of ILC2s as interacting regulators in asthma
- Evidence profile: epithelial alarmins, stromal and neuronal cues, ILC2 cytokines, asthma severity associations, lung inflammation models, and ILC2 plasticity.
- Knowledge note status: source-reviewed review note suitable for ILC2 asthma regulatory architecture.
Evidence Profile
- Overall confidence: medium for review-level organization of ILC2 asthma regulation; primary sources should anchor individual claims.
- Evidence tags: #source/review #species/mixed #tissue/lung #cell/ILC2 #assay/in_vivo #assay/scRNAseq #outcome/airway_hyperresponsiveness #outcome/inflammation #axis/ILC_airway_inflammation #axis/ILC_plasticity #status/focused_crystallization
- Primary biological axis: ILC2s integrate epithelial, stromal, neuronal, and inflammatory cues to regulate asthma pathology and potential plasticity.
Why It Matters Here
This review is a good regulatory-architecture source for ILC2 asthma. It helps connect alarmins, stromal cues, neuronal inputs, and plasticity without turning any one pathway into a universal driver.
Key Findings
- The review frames lung ILC2s as rapid responders to local environmental cues that produce IL-5 and IL-13 after tissue damage or infection.
- It emphasizes ILC2 association with allergic asthma severity and experimental lung-inflammation pathology.
- It highlights stromal and neuronal microenvironmental cues as important regulators of ILC2 function.
- It recognizes ILC2 plasticity as an important interpretive issue for asthma mechanisms.
Claim-Level Confidence
- Medium confidence: ILC2 asthma regulation is multi-input and niche-conditioned.
- Low-to-medium confidence: individual regulatory pathways should be promoted only when paired with primary sources.
- Low confidence: review-level statements should not be used as direct proof of human therapeutic efficacy.
Methods and Context
- Source type: review.
- Evidence directness: synthesis of mouse and human ILC2 literature.
- Best wiki use: ILC2 regulatory architecture, asthma overview, and reading-route support.
Caveats
- Review-level synthesis should not replace source-specific model labels.
- Some mechanisms are mouse-heavy; keep human translation explicit.
- Use this page to orient readers before sending them to primary source notes.
Contradiction and Supersession
- Contradiction status: complements focused primary ILC2 asthma sources.
- Supersession status: not superseded; newer 2024-2026 sources refine specific branches.
Related Pages
- ILC2
- ILC3
- ILC2 roles in pulmonary disease
- ILC2 functional regulation mechanisms
- ILC3 roles in pulmonary disease
- ILC3 functional regulation mechanisms
- Lung ILC Core Evidence Synthesis
- ILC In Lung